Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

NCT00093366 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: etanercept
DRUG: arsenic trioxide

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]